Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00725348
What this trial is testing

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 19
Large-scale testing (Phase 3)WithdrawnNCT01121081
What this trial is testing

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Who this might be right for
Psoriasis
Sheba Medical Center
Testing effectiveness (Phase 2)Study completedNCT03764475
What this trial is testing

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 332
Large-scale testing (Phase 3)Study completedNCT03219437
What this trial is testing

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 104
Testing effectiveness (Phase 2)Study completedNCT01384630
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 8
Testing effectiveness (Phase 2)Study completedNCT04173637
What this trial is testing

Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 330
Large-scale testing (Phase 3)Study completedNCT03930186
What this trial is testing

A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy

Who this might be right for
Plaque Psoriasis
Amgen 152
Testing effectiveness (Phase 2)Study completedNCT02995473
What this trial is testing

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Who this might be right for
Psoriasis
Galderma R&D 61
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Testing effectiveness (Phase 2)Study completedNCT02129777
What this trial is testing

Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 122
Early research (Phase 1)Study completedNCT01484587
What this trial is testing

The Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT03058744
What this trial is testing

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 94
Post-approval studies (Phase 4)Looking for participantsNCT03987763
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT04746911
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 10
Not applicableStudy completedNCT05803187
What this trial is testing

Clinical Study of Stage IV Psoriasis in Children With Geleli

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 80
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Early research (Phase 1)Study completedNCT01140061
What this trial is testing

Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)

Who this might be right for
Plaque Psoriasis
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Study completedNCT05003531
What this trial is testing

Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 250
Post-approval studies (Phase 4)Study completedNCT02186665
What this trial is testing

Plaque Psoriasis Study in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Galderma R&D 19
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation